RxSight stockholders re-elect three Class I directors and ratify EY as auditor at 2022 annual meeting

RxSight, Inc.

Ron Kurtz, J. Andy Corley, and Juliet Tammenoms Bakker re-elected as Class I directors with over 18.3M votes for each.
Ernst & Young LLP ratified as independent auditor for FY2022 with 22,575,352 votes for, 2,827 against, 118,118 abstain.
Approximately 82.6% of outstanding shares (22.7M of 27.5M) were represented at the virtual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.